[Clinical experience in prophylactic enoxaparin dosage adjustment guided by anti-Xa factor levels in critical care patients with COVID-19 pneumonia: Observational study].

ABSTRACT:

SUBMITTER: Del Carmen Bermudez-Ruiz M 

PROVIDER: S-EPMC10165054 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature